To Evaluate the Outcome of Combined Therapy of Cyproterone Acetate and Ethinyl Estradiol in PCOS

The study evaluated the effects of combined therapy using cyproterone acetate and ethinyl estradiol in patients with Polycystic Ovary Syndrome (PCOS). It involved collecting detailed clinical, menstrual, past, and family histories during the initial patient visit. The research focused on determining the duration of clinical hyperandrogenism by noting the onset of symptoms such as hirsutism, acne, alopecia, menstrual dysfunction, and weight gain. The study aimed to assess the therapeutic outcomes of this combined treatment approach in managing these symptoms associated with PCOS.